autologous melanoma cell vaccine (Dana-Farber)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameautologous melanoma cell vaccine (Dana-Farber)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptideCell and gene therapy > Cell therapyVaccines > Application > Therapeutic vaccine
Mechanisms of ActionGranulocyte-macrophage colony-stimulating factor receptor stimulants
TargetsGranulocyte-macrophage colony-stimulating factor receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesDana-Farber Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesDana-Farber Cancer Institute
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A